4-Methylumbelliferone Targets Revealed by Public Data Analysis and Liver Transcriptome Sequencing

4-methylumbelliferone (4MU) is a well-known hyaluronic acid synthesis inhibitor and an approved drug for the treatment of cholestasis. In animal models, 4MU decreases inflammation, reduces fibrosis, and lowers body weight, serum cholesterol, and insulin resistance. It also inhibits tumor progression...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsitrina, Alexandra A., Halimani, Noreen, Andreichenko, Irina N., Sabirov, Marat, Nesterchuk, Mikhail, Dashenkova, Nataliya O., Romanov, Roman, Bulgakova, Elena V., Mikaelyan, Arsen, Kotelevtsev, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917189/
https://www.ncbi.nlm.nih.gov/pubmed/36768453
http://dx.doi.org/10.3390/ijms24032129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917189/
https://www.ncbi.nlm.nih.gov/pubmed/36768453
http://dx.doi.org/10.3390/ijms24032129

Ejemplares similares